We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,111 results
  1. Safety of non-standard regimen of systemic steroid therapy in patients with Graves’ orbitopathy: a single-centre experience

    Background

    Graves’ orbitopathy (GO) is an autoimmune disorder of the orbit and retro-ocular tissues and the primary extrathyroidal manifestation of...

    Nadia Sawicka-Gutaj, Dawid Gruszczyński, ... Marek Ruchała in Pharmacological Reports
    Article Open access 26 January 2024
  2. Building a Competency Framework to Integrate Inter-disciplinary Precision Medicine Capabilities into the Medical Technology and Pharmaceutical Industry

    Introduction

    Integration of precision medicine (PM) competencies across the Medical Technology and Pharmaceutical industry is critical to enable...

    Nicholette Conway, Orin Chisholm in Therapeutic Innovation & Regulatory Science
    Article Open access 15 March 2024
  3. Opportunities and Risks of UK Medical Device Reform

    Objectives

    To identify the potential opportunities and risks around future UK regulatory reform of medical devices.

    Design

    A mixed methods approach,...

    Ji Eun Diana Han, Hussein Ibrahim, ... Melanie J. Calvert in Therapeutic Innovation & Regulatory Science
    Article Open access 13 April 2022
  4. The Medical Information Scientific Process: Define, Research, Evaluate, Synthesize, and Share (DRESS)

    Medical information (MI) professionals are primarily responsible for researching and responding to unsolicited requests for information on their...

    Dominick Albano, Farah Pragga, ... Evelyn R. Hermes-DeSantis in Therapeutic Innovation & Regulatory Science
    Article Open access 03 March 2022
  5. Drug poisoning in nursing homes: a retrospective study of data from the Danish Poison Information Centre

    Background

    Medication errors are common in nursing homes and may result in poisonings and hospitalizations.

    Objective

    This study describes potential...

    Helle Neel Jakobsen, Charlotte Vermehren, ... Kim Dalhoff in Drugs & Therapy Perspectives
    Article 11 June 2021
  6. Diabetes, hypertension and dyslipidemia medication prescribing in Qatari primary care settings: a retrospective analysis of electronic medical records

    Background

    Globally, non-communicable diseases (NCDs) are recognised as a leading cause of morbidity and mortality. Medications and medicines...

    Mohamed Ahmed Syed, Ahmed Sameer Al Nuaimi, ... Uzma Razaq in Journal of Pharmaceutical Policy and Practice
    Article Open access 11 August 2021
  7. Incidence and control of steroid-induced hyperglycaemia in hospitalised patients at a tertiary care centre for lung diseases

    Background

    The aim of this study was to determine the incidence of steroid-induced hyperglycaemia (SIH) in patients hospitalised at the tertiary...

    Matej Dobravc Verbič, Jasna Gruban, Mojca Kerec Kos in Pharmacological Reports
    Article 02 March 2021
  8. Principles and Considerations for Responsible Sharing of Safety Information Via the Medical Information Channel

    The approach used by medical information services in answering unsolicited safety-related questions from health care professionals regarding...

    Sashka Hristoskova, James Milligan, ... Robyn Rennick in Therapeutic Innovation & Regulatory Science
    Article Open access 06 January 2020
  9. Depression in patients receiving pharmacotherapy for epilepsy: An audit in a tertiary care centre

    Background

    The association of depression and epilepsy is thought to be bidirectional. The present study aimed to evaluate the prevalence of depression...

    Rupa Joshi, Manjari Tripathi, ... Yogendra Kumar Gupta in Pharmacological Reports
    Article 01 May 2019
  10. Regulatory Pathways Supporting Expedited Drug Development and Approval in ICH Member Countries

    Regulators and pharmaceutical companies across the world are intensifying efforts to get increasingly complex and innovative drugs to patients with...

    Pedro Franco, Ritesh Jain, ... Marén U. Koban in Therapeutic Innovation & Regulatory Science
    Article Open access 03 December 2022
  11. Systematic review for the development of a pharmaceutical and medical products prioritization framework

    Objective

    To identify and analyze the criteria, approaches, and conceptual frameworks, used for national/international priority setting.

    ...
    Alberto Frutos Pérez-Surio, Mercedes Gimeno-Gracia, ... Ma. del Tránsito Salvador Gómez in Journal of Pharmaceutical Policy and Practice
    Article Open access 21 August 2019
  12. Disaster Management and Emergency Preparedness in Low- and Middle-Income Countries

    Disaster is an event that causes significant damage, destruction, and human suffering. The imbalance between needs and available resources...
    Reference work entry 2023
  13. Patient Engagement and Patient Experience Data in Regulatory Review and Health Technology Assessment: A Global Landscape Review

    Background

    Working with patients through meaningful patient engagement (PE) and incorporating patient experience data (PXD) is increasingly important...

    Neil Bertelsen, Lode Dewulf, ... Nicholas Brooke in Therapeutic Innovation & Regulatory Science
    Article Open access 24 September 2023
  14. Intravenous human immunoglobulin utilization patterns and cost analysis in a Malaysian tertiary referral hospital

    Introduction

    While intravenous human immunoglobulin therapy is potentially lifesaving for rare diseases, the significant costs associated with its...

    Shea Jiun Choo, Chun Zheng Ng, ... Chee Tao Chang in Journal of Pharmaceutical Policy and Practice
    Article Open access 26 April 2022
  15. Consider cannabinoids as an individual therapeutic trial in nociplastic pain

    Nociplastic pain, which is characterized by widespread chronic pain and a range of central nervous system and other somatic symptoms, is associated...

    Esther S. Kim, Connie Kang in Drugs & Therapy Perspectives
    Article 22 November 2022
  16. Counting the cost of public and philanthropic R&D funding: the case of olaparib

    Background

    Lack of transparency around manufacturing costs, who bears the bulk of research and development costs and how total costs relate to the...

    L. Schmidt, O. Sehic, C. Wild in Journal of Pharmaceutical Policy and Practice
    Article Open access 16 August 2022
  17. Healthcare-associated infections in Africa: a systematic review and meta-analysis of point prevalence studies

    Background

    There is limited data to describe the point-prevalence of healthcare-associated infections (HAIs) among patients at a regional level in...

    Usman Abubakar, Omalhassan Amir, Jesús Rodríguez-Baño in Journal of Pharmaceutical Policy and Practice
    Article Open access 09 December 2022
  18. Adherence to metformin in adults with type 2 diabetes: a combined method approach

    Background

    Medication adherence, one of the most important aspects in the process of optimal medicines use, is unfortunately still a major challenge...

    Nadia Farhanah Syafhan, Rosemary Donnelly, ... James C. McElnay in Journal of Pharmaceutical Policy and Practice
    Article Open access 12 October 2022
  19. Understanding system-focused barriers to the identification and reporting of medication errors and adverse drug events in emergency medical services

    Introduction

    Emergency medical services (EMS) represent an important and increasingly used entry point into the healthcare system. These services are...

    Ian Howard, Nicholas Castle, ... Robert Owen in Drugs & Therapy Perspectives
    Article Open access 23 April 2019
  20. Drug-related problems and associated factors in Ethiopia: a systematic review and meta-analysis

    Background

    Drug-related problems (DRPs) can occur at any stages of medication use processes, and a single drug could be associated with multiple DRPs....

    Fuad Adem, Jemal Abdela, ... Mohammed A. Mohammed in Journal of Pharmaceutical Policy and Practice
    Article Open access 26 April 2021
Did you find what you were looking for? Share feedback.